Related Experiment Video
Updated: Aug 18, 2025
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
5.9K
Therapies for Type 1 Diabetes: Is a Cure Possible?
Neihenuo Chuzho1,2, Neetu Mishra2, Nikhil Tandon3
1ICMR-National Institute of Pathology, Safdarjung Hospital Campus, New Delhi, India.
Current Diabetes Reviews
|December 8, 2022
Summary
This review explores emerging type 1 diabetes (T1D) treatments beyond insulin, including cell replacement, immunotherapy, and artificial pancreas technologies. It examines challenges and future potential for T1D management and cures.
Area of Science:
- Endocrinology and Metabolism
- Regenerative Medicine
- Immunology
Background:
- Current type 1 diabetes (T1D) management relies on exogenous insulin to control blood glucose.
- Significant research is directed towards predicting, preventing, and curing T1D.
- Novel therapeutic strategies are emerging to address the limitations of conventional T1D treatment.
Approach:
- This review synthesizes current research on advanced T1D therapies.
- It examines β-cell replacement, immunotherapy, gene and stem cell therapies, and artificial pancreas systems.
- Non-traditional alternative therapies are also considered.
Key Points:
- Islet transplantation and stem cell therapies aim for β-cell restoration.
- Immunotherapies target the autoimmune destruction of pancreatic cells.
- Artificial pancreas technology offers automated glucose control.
- Non-traditional therapies are gaining traction as complementary options.
Conclusions:
- Multiple promising therapeutic avenues are under development for type 1 diabetes.
- Significant challenges remain in efficacy, safety, and accessibility for these advanced treatments.
- These innovative strategies hold the potential to revolutionize type 1 diabetes care and offer curative possibilities.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
328
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
328
01:22Diabetes Mellitus: Overview and Type I Subtype
2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.9K
01:22Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
01:15Diabetes: Symptoms, Diagnosis, and Complications
645
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
645
01:36Carbohydrate Metabolism
11.4K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.4K
01:16Insulin: Dosing Regimen and Adverse Effects
226
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
226